ArentFox Schiff Awarded Firm of the Year for Hatch-Waxman Litigation by LMG Life Sciences

ArentFox Schiff is proud to announce that the firm has been recognized as "Firm of the Year – Hatch-Waxman Litigation" at the LMG Life Sciences Americas Awards 2023.

The LMG Life Sciences Award program celebrates the best in practice across four main areas: financial and corporate, intellectual property, non-IP litigation, and regulatory. Information for these awards is collected through direct interviews with key clients and stakeholders in the life sciences sector. The firm was previously short-listed in four categories.

ArentFox Schiff’s Hatch-Waxman Litigation team offers comprehensive legal, business, regulatory, and scientific counsel to pharmaceutical and medical device manufacturers, as well as healthcare and life sciences companies. With more than two decades of experience, the team handles product screening, ANDA and 505(b)(2) litigation, IPR/PGR proceedings, patent validity and infringement analyses, and FDA regulatory counseling.

Smart In Your World
Your goals define our mission. Whether an immediate need or a long-term objective, ArentFox Schiff helps you reach your full potential. As industry insiders, we partner with you to develop practical business strategies and sophisticated legal solutions to achieve today’s targets and anticipate tomorrow’s problems. We get you across the finish line.


Continue Reading